Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®
Clinical trial NCT05771155 · UNKNOWN
Trial details
- NCT number
- NCT05771155
- Sponsor
- Polpharma Biologics S.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-24
- Primary completion
- 2025-09-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.